Global Erythromycin Ethylsuccinate Sales Market Report 2021

SKU ID :QYR-17423249 | Published Date: 19-Feb-2021 | No. of pages: 138
Erythromycin Ethylsuccinate is the ethylsuccinate salt form of erythromycin, a broad-spectrum, topical macrolide antibiotic with antibacterial activity. Erythromycin ethylsuccinate diffuses through the bacterial cell membrane and reversibly binds to the 50S subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin ethylsuccinate may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved.
Treatment of acute and chronic vaginal infections eg, vaginitis and vulvo-vaginitis, mixed infections and unspecific infections due to Gardnerella vaginalis, fungal infections caused by Candida albicans, trichomonal infections, and for pre- and postoperative disinfection of the vagina.

Market Analysis and Insights: Global Erythromycin Ethylsuccinate Market
The global Erythromycin Ethylsuccinate market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Erythromycin Ethylsuccinate Scope and Market Size
The global Erythromycin Ethylsuccinate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Erythromycin Ethylsuccinate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
0.1g
0.25g

Segment by Application
Anti-Bacterial Agents
Enzyme Inhibitors
Protein Synthesis Inhibitors
Gastrointestinal Agents

The Erythromycin Ethylsuccinate market is analysed and market size information is provided by regions (countries). Segment by Application, the Erythromycin Ethylsuccinate market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Chemenu Inc.
Acorn PharmaTech,LLC
BLD Pharm
Boc Sciences
Bide Pharmatech Ltd.
  • PRICE
  • $4000
    $8000
    $6000
    Buy Now

Our Clients